ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 177 filers reported holding ARGENX SE in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $140,756,661 | +38.8% | 286,310 | +10.1% | 0.25% | +42.9% |
| Q2 2023 | $101,392,119 | +2.0% | 260,158 | -2.5% | 0.18% | -4.3% |
| Q1 2023 | $99,433,372 | +53.1% | 266,874 | +55.7% | 0.18% | +28.5% |
| Q4 2022 | $64,926,862 | +2.5% | 171,385 | -4.5% | 0.14% | +2.1% |
| Q3 2022 | $63,367,000 | -5.1% | 179,483 | +1.9% | 0.14% | -2.1% |
| Q2 2022 | $66,776,000 | +8.5% | 176,153 | -9.7% | 0.14% | +16.1% |
| Q1 2022 | $61,561,000 | -2.2% | 195,131 | +8.6% | 0.12% | +5.1% |
| Q4 2021 | $62,929,000 | +38.9% | 179,720 | +19.8% | 0.12% | +24.2% |
| Q3 2021 | $45,304,000 | +5.9% | 150,001 | +5.6% | 0.10% | 0.0% |
| Q2 2021 | $42,765,000 | +21.7% | 142,037 | +11.3% | 0.10% | +6.7% |
| Q1 2021 | $35,131,000 | +40.8% | 127,569 | +50.3% | 0.09% | +36.9% |
| Q4 2020 | $24,956,000 | +77.1% | 84,860 | +58.1% | 0.06% | +58.5% |
| Q3 2020 | $14,093,000 | +52.8% | 53,684 | +31.1% | 0.04% | +41.4% |
| Q2 2020 | $9,221,000 | +90.2% | 40,940 | +11.2% | 0.03% | +61.1% |
| Q1 2020 | $4,848,000 | +16.5% | 36,801 | +42.0% | 0.02% | +50.0% |
| Q4 2019 | $4,161,000 | +35.4% | 25,919 | -3.9% | 0.01% | +50.0% |
| Q3 2019 | $3,073,000 | -8.3% | 26,966 | +14.0% | 0.01% | -27.3% |
| Q2 2019 | $3,350,000 | +109.0% | 23,663 | +84.3% | 0.01% | +120.0% |
| Q1 2019 | $1,603,000 | – | 12,842 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 297,701 | $112,778,070 | 70.21% |
| Artia Global Partners LP | 85,204 | $32,277,831 | 12.30% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,430,201 | 7.16% |
| DCF Advisers, LLC | 25,000 | $9,470,750 | 6.40% |
| Eagle Health Investments LP | 60,300 | $22,843,449 | 5.27% |
| Avidity Partners Management LP | 625,000 | $236,768,750 | 5.13% |
| Bellevue Group AG | 911,100 | $345,152,013 | 4.58% |
| Fairmount Funds Management LLC | 73,526 | $27,853,855 | 4.42% |
| Paradigm Biocapital Advisors LP | 89,556 | $33,926,499 | 3.98% |
| RTW INVESTMENTS, LP | 482,195 | $182,669,932 | 3.73% |